<DOC>
	<DOCNO>NCT00586066</DOCNO>
	<brief_summary>The purpose study see whether Memantine improve memory function subject bipolar disorder minimal symptom . Secondary analysis test role Memantine improve residual mood symptom ( depression mania ) subject bipolar disorder . We hypothesize subject bipolar disorder minimal symptom Memantine effective improve cognitive function , measure difference neuropsychological test score begin end trial .</brief_summary>
	<brief_title>Memantine Cognitive Dysfunction Bipolar Disorder</brief_title>
	<detailed_description>A large proportion subject bipolar disorder experience significant cognitive dysfunction , even euthymic , adequate treatment . The cognitive deficit asymptomatic patient bipolar disorder important subject 's psychosocial function . In population , cognitive deficit associate poor psychosocial functioning , inability hold job . Memantine glutamate N-methyl-D-aspartate ( NMDA ) receptor antagonist show efficacy cognitive dysfunction due moderate severe Alzheimer disease . Demonstrating role Memantine reduce cognitive dysfunction minimally symptomatic subject bipolar disorder promise provide important clinical information , could lead improvement well-being functional status large population subject bipolar disorder .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>Diagnostic Statistical ManualIV diagnostic criterion bipolar disorder ( type I , type II , NOS ) ( diagnose use Structured Clinical Interview DSMIVTR Mood Module ( SCID Mood Module ) Written informed consent Men woman age 1865 A baseline HamiltonD 17 score &lt; 10 screen baseline visit . A baseline Young Mania Rating Scale score &lt; 10 screen baseline visit . No acute episode depression mania previous 12 week . Massachusetts General Hospital Cognitive Physical Functioning Scale : Cutoff : &gt; 15 Everyday Cognition SelfReport Form : Average item &gt; 1.5 Repeatable Battery Assessment Neuropsychological Status ( RBANS ) : &lt; 12 year education , RBANS total scale score &lt; 85 =12 year education , RBANS total scale score &lt; 93 &gt; 12 year education , RBANS total scale score &lt; 100 Able read understand English . Patients meet follow criterion exclude study : Subjects suicidal ideation outpatient treatment determine unsafe study clinician . These patient immediately refer appropriate clinical treatment . Pregnant woman , nurse mother , woman childbearing potential use medically accept mean contraception ( defined oral contraceptive pill implant , condom , diaphragm , spermicide , intrauterine device ( IUD ) , s/p tubal ligation , partner vasectomy ) . Serious unstable medical illness , include liver impairment , kidney impairment , cardiovascular , hepatic , respiratory , endocrine , neurologic hematologic disease . History seizure disorder , brain injury , history know neurological disease ( multiple sclerosis , degenerative disease ALS , Parkinson disease movement disorder , etc ) . History current diagnosis follow DSMIV psychiatric illness : organic mental disorder , schizophrenia , schizoaffective disorder , delusional disorder , psychotic disorder otherwise specify , major depressive disorder , patient substance dependence disorder , include alcohol , active within last 12 month . History multiple adverse drug reaction . Patients mood congruent mood incongruent psychotic feature within last 12 month . Clinical laboratory evidence hypothyroidism . Patients episode acute depression mania 12 week prior enrollment . Patients electroconvulsive therapy ( ECT ) within 6 month precede enrollment . Patients take drug alkalinize urine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Bipolar disorder</keyword>
	<keyword>Cognitive dysfunction</keyword>
	<keyword>Memantine</keyword>
	<keyword>NMDA antagonist</keyword>
</DOC>